📊 CMT Key Takeaways
Investment Thesis
CMT demonstrates solid financial health with strong liquidity (3.02x current ratio) and conservative leverage (0.11x debt/equity), but faces headwinds from declining revenue (-9.5% YoY) and deteriorating profitability (-15.8% net income decline). The company generates positive free cash flow despite margin compression, suggesting underlying operational challenges in a cyclical plastics manufacturing industry.
CMT Strengths
- Exceptional liquidity position with 3.02x current ratio and $38.1M cash on balance sheet
- Conservative capital structure with minimal leverage (0.11x debt/equity ratio) and strong interest coverage (14,218x)
- Positive free cash flow generation of $1.9M despite revenue contraction and modest capital expenditure discipline
CMT Risks
- Revenue declining 9.5% year-over-year indicating loss of market share or cyclical downturn in plastics demand
- Net income falling 15.8% faster than revenue decline shows operating leverage working in reverse and margin compression
- Weak free cash flow margin of 0.7% and low ROE of 7.1% suggest inefficient capital deployment and limited earnings power
- Significant insider trading activity (15 Form 4 filings in 90 days) warrants monitoring for potential negative signals
Key Metrics to Watch
- Revenue stabilization and return to growth trajectory
- Operating margin recovery (currently at 5.2%, historically higher expected)
- Free cash flow conversion rate and capital allocation decisions
- Customer retention and order book trends
CMT Financial Metrics
💡 AI Analyst Insight
The relatively thin 0.7% FCF margin may limit capital allocation flexibility. Strong liquidity with a 3.02x current ratio provides a solid financial cushion.
CMT Profitability Ratios
CMT vs Default Sector
How CORE MOLDING TECHNOLOGIES INC compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CMT Balance Sheet & Liquidity
CMT 5-Year Financial Trend
5-Year Trend Summary: CORE MOLDING TECHNOLOGIES INC's revenue has remained relatively flat over the 5-year period, with a 5% decline. The most recent EPS of $0.69 reflects profitable operations.
CMT Growth Metrics (YoY)
CMT Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $58.4M | $1.9M | $0.22 |
| Q2 2025 | $79.2M | $4.1M | $0.47 |
| Q1 2025 | $61.4M | $2.2M | $0.25 |
| Q3 2024 | $73.0M | $3.2M | $0.36 |
| Q2 2024 | $88.7M | $6.4M | $0.73 |
| Q1 2024 | $78.1M | $3.8M | $0.43 |
| Q3 2023 | $86.7M | $1.3M | $0.16 |
| Q2 2023 | $97.7M | $2.2M | $0.26 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CMT Capital Allocation
CMT SEC Filings
Access official SEC EDGAR filings for CORE MOLDING TECHNOLOGIES INC (CIK: 0001026655)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CMT
What is the AI rating for CMT?
CORE MOLDING TECHNOLOGIES INC (CMT) has an AI rating of HOLD with 62% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CMT's key strengths?
Exceptional liquidity position with 3.02x current ratio and $38.1M cash on balance sheet. Conservative capital structure with minimal leverage (0.11x debt/equity ratio) and strong interest coverage (14,218x).
What are the risks of investing in CMT?
Revenue declining 9.5% year-over-year indicating loss of market share or cyclical downturn in plastics demand. Net income falling 15.8% faster than revenue decline shows operating leverage working in reverse and margin compression.
What is CMT's revenue and growth?
CORE MOLDING TECHNOLOGIES INC reported revenue of $273.8M.
Does CMT pay dividends?
CORE MOLDING TECHNOLOGIES INC does not currently pay dividends.
Where can I find CMT SEC filings?
Official SEC filings for CORE MOLDING TECHNOLOGIES INC (CIK: 0001026655) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CMT's EPS?
CORE MOLDING TECHNOLOGIES INC has a diluted EPS of $1.29.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.